CD23 is type II membrane glycoprotein and is primary expressed on the surface of a sub-population of B-cells in germinal center (mantle zone, and follicular dendritic cells)
Intended use
CD23 is detected in neoplastic cells from B-cell chronic lymphocytic leukemia/lymphoma (B-CLL) and absent in mantle cell lymphoma. It is a useful tool for identifying/classifying a range of leukemias and
lymphomas when used with a panel of antibodies
Comments
0 comments
Please sign in to leave a comment.